NCT00272012View on ClinicalTrials.gov

OPAL - Insulin Glulisine, Diabetes Mellitus

PHASE3CompletedINTERVENTIONAL

Enrollment

396

Participants

Timeline

Start Date

July 31, 2004

Primary Completion Date

September 30, 2006

Conditions

Diabetes Mellitus Type 2

Interventions

DRUG

Insulin glulisine

Trial Locations (1)

Unknown

Sanofi-Aventis, Berlin

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Sanofi

INDUSTRY